The nCounter PanCancer Immune Profiling Panel was used to explore differences in the TME between mice bearing EMT6 tumors (murine triple-negative breast cancer model) (26) that were treated with a vehicle control or the BET inhibitor PLX51107. The gene discussed is DNER; the disease is triple-negative breast carcinoma.